Analysis | High drug prices are not justified by industry’s spending on research and development
21 Feb, 2023 | 11:41h | UTCHigh drug prices are not justified by industry’s spending on research and development – The BMJ
News Release: Drug prices not justified by industry’s research and development spending – BMJ Newsroom
Commentary from the author on Twitter (thread – click for more)
New @bmj_latest paper?
High drug prices do not seem justified by pharma industry’s R&D spending & new drugs' added benefits ??
How can companies develop more innovative & affordable medicines?Read the thread ?https://t.co/YYznD4Tvwq@ojwouters @ElsTorreele @martinmckee
— Aris Angelis (@Aris_Angelis) February 16, 2023